From EGM notes:"Hoping to incorporate reserve upgrade in Annual Report (early Oct) "Ref: https://tinyurl.com/y2szuv75
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%